Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis
Marla C. Dubinsky 1, Lorna Charles 2, Krzysztof W. Selmaj 3, Giancarlo Comi 4, Anthony Krakovich 2, C. Janneke van der Woude 5, Uma Mahadevan 6
1 Susan and Leonard Feinstein IBD Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2 Bristol Myers Squibb, Princeton, NJ, USA; 3 Center for Neurology, Lodz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland; 4 Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy; 5 Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands; 6 Gastroenterology Division, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
;
